Northwestern Mutual Wealth Management
ADMA icon

Northwestern Mutual Wealth Management’s ADMA Biologics ADMA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Sell
177
-69
-28% -$629 ﹤0.01% 3720
2026
Q1 		$2.22K Sell
246
-232
-49% -$3.66K ﹤0.01% 3569
2025
Q4 		$8.72K Buy
+478
New +$8.06K ﹤0.01% 3043

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northwestern Mutual Wealth Management's ADMA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its ADMA Biologics (ADMA) stake by 28% in Q2 2026, selling an estimated $629 and leaving 177 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3720.

Northwestern Mutual Wealth Management first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.72K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 177 shares of ADMA Biologics worth $1.48K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 69 ADMA Biologics shares in Q2 2026, an estimated $629.
  • ADMA Biologics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3720 holding.
  • Northwestern Mutual Wealth Management first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's ADMA Biologics position peaked at $8.72K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.